Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Sarcoma 1

Conditions

Sarcoma 1 Neoplasm Metastasis 1

Interventions

Specimen Handling 39 Magnetic Resonance Spectroscopy 33 Cyclophosphamide 30 Doxorubicin 24 Biopsy 24 pembrolizumab 22 Temozolomide 22 Radiotherapy 20 Radiation 19 X-Rays 18 Nivolumab 15 Vincristine 13 Irinotecan 13 fludarabine 12 Phantoms, Imaging 12 Ifosfamide 12 Gemcitabine 12 atezolizumab 11 cabozantinib 10 Ipilimumab 9 Bevacizumab 9 liposomal doxorubicin 8 Surgical Procedures, Operative 8 Paclitaxel 8 Immunoglobulin G 8 Etoposide 8 Dactinomycin 7 Carboplatin 7 palbociclib 6 olaparib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

glasdegib × Sarcoma × 90 days × Clear all

NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡